Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $35.67 $43.20 Thursday, 9th May 2024 CLDX stock ended at $41.06. This is 0.364% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.12% from a day low at $41.01 to a day high of $41.88.
90 days $35.03 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Jul 06, 2016 $67.50 $70.05 $66.75 $69.45 115 333
Jul 05, 2016 $68.25 $68.85 $67.05 $67.80 82 860
Jul 01, 2016 $66.00 $69.75 $65.55 $68.85 147 060
Jun 30, 2016 $66.00 $67.05 $64.65 $65.85 114 007
Jun 29, 2016 $66.60 $66.60 $63.45 $66.30 158 627
Jun 28, 2016 $62.55 $65.40 $62.55 $65.25 187 413
Jun 27, 2016 $64.05 $65.85 $61.35 $61.35 198 033
Jun 24, 2016 $62.40 $67.35 $62.25 $65.40 368 760
Jun 23, 2016 $67.80 $68.70 $66.15 $68.55 146 833
Jun 22, 2016 $66.75 $70.20 $65.25 $66.75 149 173
Jun 21, 2016 $66.15 $67.05 $64.50 $66.90 156 947
Jun 20, 2016 $65.10 $66.90 $63.75 $66.15 120 867
Jun 17, 2016 $66.30 $66.75 $63.75 $64.05 484 427
Jun 16, 2016 $63.45 $66.45 $61.80 $66.15 126 527
Jun 15, 2016 $63.75 $64.50 $61.65 $63.75 145 098
Jun 14, 2016 $60.45 $63.00 $60.15 $62.25 164 361
Jun 13, 2016 $61.80 $62.40 $59.55 $60.75 168 214
Jun 10, 2016 $63.90 $64.65 $61.05 $61.80 157 876
Jun 09, 2016 $70.20 $71.85 $64.65 $64.80 179 451
Jun 08, 2016 $70.05 $71.70 $69.00 $70.80 132 980
Jun 07, 2016 $72.90 $73.35 $69.45 $69.90 175 650
Jun 06, 2016 $70.65 $73.50 $68.40 $72.90 250 476
Jun 03, 2016 $75.30 $76.95 $68.25 $68.40 336 900
Jun 02, 2016 $68.25 $75.00 $67.65 $75.00 294 125
Jun 01, 2016 $68.25 $69.30 $66.15 $68.25 201 979
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT